Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study

Autor: Hellemans, R. *, †, Hazzan, M. †, Durand, D., Mourad, G., Lang, P., Kessler, M., Charpentier, B., Touchard, G., Berthoux, F., Merville, P., Ouali, N., Squifflet, J.-P., Bayle, F., Wissing, K.M., Noël, C., Abramowicz, D.
Zdroj: In American Journal of Transplantation July 2015 15(7):1923-1932
Databáze: ScienceDirect
Externí odkaz: